AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

In CRS with and without nasal polyps, medical treatment, including nasal and oral corticosteroids, is the first therapeutic option. The treatment of CRS still remains an unmet need ...

Do you find yourself sneezing, itching or battling watery eyes as the seasons change? If so, you may have a pollen ...

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The company said this morning ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, as the caregiver team navigates the course of a disease." Recent advances ...

WILMINGTON, Del., November 08, 2024--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) showed that ...

Stock options listed on U.S. stock exchanges generally have a notional amount of 100 shares of stock. Stock options are also traded in the over the counter (OTC) market with variable notional amounts.

Treatment options for stretch marks (striae) can include home remedies as well as laser therapy and other medical treatments. There are mixed reviews, though, on how well they work on the discolored ...

At one time, and because of the risk management challenges involved, listed options trading was mostly done by professionals and market makers with limited public participation. Today, you can ...

It can be a symptom of nasal furunculosis, a deep infection of the hair follicle within the nasal vestibule, the area just inside the nostril. Fortunately, it’s fairly easy to treat — but if ...